TY  - GEN
AU  - Ji,Wen-Tsai
AU  - Yang,Sheng-Ru
AU  - Chen,Jeff Yi-Fu
AU  - Cheng,Ya-Ping
AU  - Lee,Ying-Ray
AU  - Chiang,Ming-Ko
AU  - Chen,Hau-Ren
TI  - Arecoline downregulates levels of p21 and p27 through the reactive oxygen species/mTOR complex 1 pathway and may contribute to oral squamous cell carcinoma
SN  - 1349-7006
PY  - 2013///0408
KW  - Arecoline
KW  - pharmacology
KW  - Blotting, Western
KW  - Carcinoma, Squamous Cell
KW  - genetics
KW  - Cell Line, Tumor
KW  - Cell Proliferation
KW  - drug effects
KW  - Cholinergic Agonists
KW  - Cyclin-Dependent Kinase Inhibitor p21
KW  - Cyclin-Dependent Kinase Inhibitor p27
KW  - DNA Damage
KW  - Down-Regulation
KW  - G1 Phase Cell Cycle Checkpoints
KW  - G2 Phase Cell Cycle Checkpoints
KW  - Humans
KW  - Male
KW  - Mechanistic Target of Rapamycin Complex 1
KW  - Microscopy, Fluorescence
KW  - Mouth Neoplasms
KW  - Multiprotein Complexes
KW  - Reactive Oxygen Species
KW  - metabolism
KW  - Reverse Transcriptase Polymerase Chain Reaction
KW  - Signal Transduction
KW  - TOR Serine-Threonine Kinases
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1111/j.1349-7006.2012.02294.x
ER  -